Insider · CIK 0001916566
Greg Tourangeau
officer
Files at FULC (Fulcrum Therapeutics, Inc.). First filing May 9, 2025, latest May 9, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $2,520 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | FULCsell Fulcrum Therapeutics, Inc. | $2,520 498 shares | -3% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 8, 2025 | FULC Fulcrum Therapeutics, Inc. | SOpen-market sale Common Stock | -498 | $5.06 | $2,520 | 14,062 | May 9, 2025 |
| Jan 24, 2025 | FULC Fulcrum Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +76,120 | $0.00 | $0 | 76,120 | Jan 28, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.